+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Human Papilloma Virus/HPV Test and Pap Smear/Test Market by Product & Service, Test Type, Technology, Application, Care Setting, and Region - Global Forecast to 2030

  • PDF Icon

    Report

  • 282 Pages
  • October 2025
  • Region: Global
  • Markets and Markets
  • ID: 5696935
The HPV testing and Pap test market is valued at an estimated USD 2.44 billion in 2025 and is projected to reach USD 3.94 billion by 2030, at a CAGR of 10.0% during the forecast period. The rising awareness of cervical cancer and the importance of timely screening is significantly boosting the HPV testing and Pap test market. Public health campaigns, government screening initiatives, and educational efforts are making women more informed about the risks associated with HPV infection and the critical role of early detection. This heightened awareness is leading to greater participation in routine screening programs, directly fueling the demand for both HPV and Pap tests. Support from healthcare providers, advocacy groups, and non-profit organizations further reinforces preventive screening as a key component of women’s healthcare. As more women gain access to information and resources about screening, test volumes are expected to rise steadily, driving sustained market growth and strengthening the role of HPV and Pap testing in reducing cervical cancer incidence worldwide.

By product & service, the consumables segment dominated the HPV testing and Pap test market in 2024.

Based on product & service, the HPV testing and Pap test market is segmented into consumables, instruments, and services. In 2024, consumables accounted for the largest share of the market. This dominance is driven by the widespread use of reagents, collection kits, and assay consumables that are essential for both HPV and Pap testing on a recurring basis.

The increasing adoption of HPV screening programs, coupled with the expansion of cervical cancer prevention initiatives, has created steady demand for these products. Consumables play a critical role in ensuring accuracy and reproducibility of test results, which is reinforced by regulatory guidelines that mandate standardized testing protocols. Moreover, the growing shift toward molecular-based HPV assays and automated cytology platforms has further increased the reliance on specialized consumables. The recurring nature of consumable usage, compared to one-time investments in instruments, positions this segment as the largest revenue contributor in the HPV testing and Pap test market.

By application, the vaginal cancer screening segment is projected to achieve the highest growth during the forecast period.

By application, the HPV testing and Pap test market is segmented into cervical cancer screening and vaginal cancer screening. While cervical cancer screening currently accounts for the majority of testing volumes due to its high prevalence and established screening guidelines, vaginal cancer screening is expected to witness the fastest growth during the forecast period.

This growth is primarily driven by increasing awareness of vaginal cancers, improvements in diagnostic sensitivity of HPV tests, and a gradual expansion of screening practices beyond cervical cancer. Rising research efforts and clinical recommendations supporting HPV testing for broader gynecologic cancer detection are also contributing to the adoption of vaginal cancer screening. Although it remains a relatively smaller segment today, the potential for early detection and improved patient outcomes is likely to accelerate demand, positioning vaginal cancer screening as a key growth area in the HPV testing and Pap test market.

The Asia Pacific is projected to be the fastest-growing regional market during the forecast period.

The market for HPV testing and Pap tests is categorized into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. The Asia Pacific region is projected to experience the fastest growth in the HPV testing and Pap test market during the forecast period. Rapid urbanization, improving healthcare infrastructure, and increasing access to diagnostic facilities are expanding screening opportunities across the region.

Government-led initiatives and public health campaigns in countries such as China, India, and Southeast Asian nations are actively promoting cervical cancer awareness and early detection programs. The rising prevalence of HPV infections and growing concerns about women’s health are driving the adoption of HPV and Pap testing. Additionally, market players are introducing cost-effective and high-throughput testing solutions tailored to local needs, further accelerating adoption. The combination of expanding healthcare access, regulatory support, and rising patient awareness positions the Asia Pacific as the fastest-growing regional segment in the global HPV testing and Pap test market.

Breakdown of the profiles of primary participants in the HPV testing and Pap test market:

  • By Company Type: Tier 1 (40%), Tier 2 (30%), and Tier 3 (30%)
  • By Designation: C-level Executives (27%), Director-level Executives (18%), and Others (55%)
  • By Region: North America (51%), Europe (21%), Asia Pacific (18%), Latin America (6%), and the Middle East & Africa (4%)
The key players in the HPV testing and Pap test market are Hologic, Inc. (US), Becton, Dickinson and Company (BD) (US), F. Hoffmann-La Roche Ltd. (Switzerland), QIAGEN (Netherlands), Danaher Corporation (US), Abbott (US), Seegene Inc. (South Korea), SD Biosensor, INC. (South Korea), Sansure Biotech Inc. (China), ACON Laboratories, Inc. (US), Molbio Diagnostics Limited (India), Tellgen Corporation (China), Daan Gene Co., Ltd. (China), Jiangsu BioPerfectus Technologies Co., Ltd (China), Anatolia Geneworks (Turkey), AB ANALITICA s.r.l. (Italy), CERTEST BIOTEC (Spain), Atila Biosystems (US), Yaneng BIOscience (Shenzhen) Co., Ltd. (China), Xiamen Zeesan Biotech Co., Ltd. (China), Advanced Molecular Diagnostics (AMD) (UK), Mylab Discovery Solutions Pvt. Ltd. (India), Sacace Biotechnologies Srl (Italy), Jiangsu Mole Bioscience Co., Ltd. (China), HANGZHOU ALLTEST BIOTECH CO., LTD. (China), Hangzhou Tongzhou Biotechnology Co., Ltd. (China), and Nanjing Liming Biological Products Co., Ltd. (China).

Research Coverage:

This research report categorizes the HPV testing and Pap test market by product & service (consumables, instruments, and services), test type [HPV testing (primary HPV testing, co-testing, and follow-up HPV testing) and Pap tests], technology (molecular diagnostics, immunodiagnostics, and cytology), application (cervical cancer screening and vaginal cancer screening), care setting (hospitals, diagnostic laboratories, and physicians’ offices & clinics), and region (North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa).

The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, opportunities, and challenges, influencing the growth of the HPV testing and Pap test market. A detailed analysis of the key industry players has been done to provide insights into their business overview, solutions, key strategies, acquisitions, and agreements. Competitive analysis of upcoming startups in the HPV testing and Pap test market ecosystem is covered in this report.

Reasons to buy this report:

The report will help market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall HPV testing and Pap test market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, opportunities, and challenges.

The report provides insights into the following pointers:

  • Analysis of key drivers (rising HPV cases and subsequent increase in cervical cancer, growing awareness of cervical cancer screening programs, and increasing R&D funding initiatives on cervical cancer prevention), opportunities (regulatory guidelines for cervical cancer screening and innovative improvements in HPV tests), restraints (growing awareness of HPV vaccinations), and challenges (uncertain reimbursement scenario, stringent regulatory & legal requirements, and operational barriers) influencing the growth of the HPV testing and Pap test market.
  • Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product launches/approvals in the HPV testing and Pap test market.
  • Market Development: Comprehensive information about lucrative markets across varied regions
  • Market Diversification: Exhaustive information about products, untapped geographies, recent developments, and investments in the HPV testing and Pap test market.
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, and product offerings of leading players like Hologic, Inc. (US), Becton, Dickinson and Company (BD) (US), F. Hoffmann-La Roche Ltd. (Switzerland), QIAGEN (Netherlands), and Danaher Corporation (US).

Table of Contents

1 Introduction
1.1 Study Objectives
1.2 Market Definition
1.3 Study Scope
1.3.1 Market Segmentation and Regional Scope
1.3.2 Inclusions and Exclusions
1.3.3 Years Considered
1.4 Currency Considered
1.5 Stakeholders
1.6 Summary of Changes
2 Research Methodology
2.1 Research Data
2.2 Research Approach
2.2.1 Secondary Data
2.2.1.1 Key Secondary Sources
2.2.1.2 Key Data from Secondary Sources
2.2.2 Primary Data
2.2.2.1 Primary Sources
2.2.2.2 Key Data from Primary Sources
2.2.2.3 Key Industry Insights
2.2.2.4 Breakdown of Primary Interviews
2.3 Market Size Estimation
2.3.1 Bottom-Up Approach
2.3.1.1 Company Revenue Estimation Approach
2.3.1.2 Presentations of Companies and Primary Interviews
2.3.1.3 Growth Forecast
2.3.1.4 CAGR Projections
2.3.1.5 Epidemiology-based Test Volume Estimation Approach
2.3.2 Top-Down Approach
2.4 Market Breakdown and Data Triangulation
2.5 Market Share Assessment
2.6 Research Assumptions
2.7 Research Limitations
2.8 Risk Assessment
3 Executive Summary
4 Premium Insights
4.1 Hpv Testing and Pap Test Market Overview
4.2 Hpv Testing and Pap Test Market, by Product & Service, 2025 vs. 2030
4.3 Hpv Testing and Pap Test Market, by Test Type, 2025 vs. 2030
4.4 Hpv Testing and Pap Test Market, by Technology, 2025 vs. 2030
4.5 Hpv Testing and Pap Test Market, by Application, 2025 vs. 2030
4.6 Hpv Testing and Pap Test Market, by Care Setting, 2025 vs. 2030
4.7 Hpv Testing and Pap Test Market: Geographic Growth Opportunities
5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Rising Hpv Cases and Subsequent Increase in Cervical Cancer
5.2.1.2 Growing Awareness About Cervical Cancer Screening Programs
5.2.1.3 Increasing R&D Funding Initiatives on Cervical Cancer Prevention
5.2.2 Restraints
5.2.2.1 Growing Awareness and Adoption of Hpv Vaccination
5.2.3 Opportunities
5.2.3.1 Regulatory Guidelines for Cervical Cancer Screening
5.2.3.2 Innovative Improvements in Hpv Tests
5.2.4 Challenges
5.2.4.1 Uncertain Reimbursement Scenario
5.2.4.2 Stringent Regulatory and Legal Requirements
5.2.4.3 Operational Barriers
5.3 Trends/Disruptions Impacting Customers’ Businesses
5.4 Pricing Analysis
5.4.1 Average Selling Price Trend of Hpv and Pap Tests
5.4.2 Average Selling Price Trend, by Key Player
5.4.3 Average Selling Price Trend, by Region
5.5 Value Chain Analysis
5.6 Supply Chain Analysis
5.7 Ecosystem Analysis
5.8 Investment and Funding Scenario
5.9 Technology Analysis
5.9.1 Key Technologies
5.9.1.1 Molecular Diagnostics
5.9.2 Complementary Technologies
5.9.2.1 Cytology
5.9.3 Adjacent Technologies
5.9.3.1 Immunodiagnostics
5.10 Key Conferences and Events, 2025-2026
5.11 Patent Analysis
5.12 Trade Analysis
5.12.1 Import Data for HS Code 3822
5.12.2 Export Data for HS Code 3822
5.13 Case Study Analysis
5.13.1 Case Study 1: Utilization of Human Papillomavirus Testing for Cervical Cancer Screening in Thailand
5.13.2 Case Study 2: Implementation of Human Papillomavirus Primary Screening of Cervical Cancer in British Columbia
5.13.3 Case Study 3: Comparative Evaluation of Hpv Self-Sampling in India
5.14 Regulatory Landscape
5.14.1 Regulatory Framework
5.14.1.1 North America
5.14.1.1.1 US
5.14.1.1.2 Canada
5.14.1.2 Europe
5.14.1.2.1 Germany
5.14.1.2.2 UK
5.14.1.2.3 France
5.14.1.2.4 Italy
5.14.1.3 Asia-Pacific
5.14.1.3.1 China
5.14.1.3.2 Japan
5.14.1.3.3 India
5.14.1.4 Latin America
5.14.1.4.1 Brazil
5.14.1.4.2 Mexico
5.14.1.5 Middle East
5.14.1.6 Africa
5.14.2 Regulatory Bodies, Government Agencies, and Other Organizations
5.15 Porter's Five Forces Analysis
5.15.1 Bargaining Power of Buyers
5.15.2 Bargaining Power of Suppliers
5.15.3 Threat of New Entrants
5.15.4 Threat of Substitutes
5.15.5 Intensity of Competitive Rivalry
5.16 Key Stakeholders and Buying Criteria
5.16.1 Key Stakeholders in Buying Process
5.16.2 Buying Criteria
5.17 Impact of AI/Generative AI on Hpv Testing and Pap Test Market
5.17.1 Introduction
5.17.2 Market Potential of AI
5.17.3 AI Use Cases
5.17.4 Key Companies Implementing AI
5.17.5 Future of AI in Hpv Testing and Pap Test Market
5.18 Impact of 2025 US Tariffs on Hpv Testing and Pap Test Market
5.18.1 Introduction
5.18.2 Key Tariff Rates
5.18.3 Price Impact Analysis
5.18.4 Impact on Country/Region
5.18.4.1 North America
5.18.4.2 Europe
5.18.4.3 Asia-Pacific
5.18.5 Impact on End-use Industries
5.18.5.1 Hospitals
5.18.5.2 Diagnostic Laboratories
5.18.5.3 Physicians’ Offices & Clinics
6 Hpv Testing and Pap Test Market, by Product & Service
6.1 Introduction
6.2 Consumables
6.2.1 Recurrent Purchases of Assays & Kits to Drive Growth
6.3 Instruments
6.3.1 Increasing Adoption of Automated Diagnostic Systems to Drive Growth
6.4 Services
6.4.1 Growing Uptake of Advanced Instruments to Drive Demand
7 Hpv Testing and Pap Test Market, by Test Type
7.1 Introduction
7.2 Hpv Testing
7.2.1 Primary Hpv Testing
7.2.1.1 Test Sensitivity and Accuracy to Drive Growth
7.2.2 Follow-Up Hpv Testing
7.2.2.1 Irregular Pap Test Results to Drive Adoption
7.2.3 Co-Testing
7.2.3.1 Co-Testing to Drive Rapid Detection Results for Cervical Cancer
7.3 Pap Tests
7.3.1 Rising Cases of False-Negative Tests to Restrain Market
8 Hpv Testing and Pap Test Market, by Technology
8.1 Introduction
8.2 Molecular Diagnostics
8.2.1 High Sensitivity and Specificity in Hpv Detection to Drive Market Growth
8.3 Immunodiagnostics
8.3.1 Cost Benefits of Immunoassays to Boost Demand
8.4 Cytology
8.4.1 Automation and Digital Imaging to Drive Adoption
9 Hpv Testing and Pap Test Market, by Application
9.1 Introduction
9.2 Cervical Cancer Screening
9.2.1 Rising Incidence of Cervical Cancer to Drive Market
9.3 Vaginal Cancer Screening
9.3.1 Limited Screening Tests to Restrain Market
10 Hpv Testing and Pap Test Market, by Care Setting
10.1 Introduction
10.2 Hospitals
10.2.1 Advanced Technologies and Equipped Facilities to Drive Market
10.3 Diagnostic Laboratories
10.3.1 Increasing Outsourcing of Diagnostic Tests to Laboratories to Drive Market
10.4 Physicians’ Offices & Clinics
10.4.1 Rapid and Efficient Results to Support Market Growth
11 Hpv Testing and Pap Test Market, by Region
11.1 Introduction
11.2 North America
11.2.1 Macroeconomic Outlook for North America
11.2.2 US
11.2.2.1 Rising Government Initiatives for Cervical Cancer Testing to Expedite Growth
11.2.3 Canada
11.2.3.1 Growing Awareness of Cervical Cancer Screening to Support Growth
11.3 Europe
11.3.1 Macroeconomic Outlook for Europe
11.3.2 Germany
11.3.2.1 Established Healthcare Infrastructure and Rising Healthcare Spending to Promote Growth
11.3.3 UK
11.3.3.1 Rising Focus on Research Projects for Specific Cancers to Contribute to Growth
11.3.4 France
11.3.4.1 High Incidence of Cervical Cancer and Associated Investments in Genomics to Stimulate Growth
11.3.5 Italy
11.3.5.1 Growing Acceptance of Molecular-based Diagnostic Tests for Cervical Cancer Screening to Boost Market
11.3.6 Spain
11.3.6.1 Increasing Research on Cancer Diagnostics to Accelerate Growth
11.3.7 Rest of Europe
11.4 Asia-Pacific
11.4.1 Macroeconomic Outlook for Asia-Pacific
11.4.2 China
11.4.2.1 Growing Public Access to Modern Healthcare to Propel Market
11.4.3 Japan
11.4.3.1 Rising Demand for Technologically Advanced Cervical Cancer Screening Tests to Facilitate Growth
11.4.4 India
11.4.4.1 Expanding Healthcare Access and High Cervical Cancer Burden to Drive Market
11.4.5 Rest of Asia-Pacific
11.5 Latin America
11.5.1 Macroeconomic Outlook for Latin America
11.5.2 Brazil
11.5.2.1 Universal Healthcare Access to Speed Up Growth
11.5.3 Mexico
11.5.3.1 Improved Access to Healthcare to Sustain Growth
11.5.4 Rest of Latin America
11.6 Middle East & Africa
11.6.1 Macroeconomic Outlook for Middle East & Africa
11.6.2 Saudi Arabia
11.6.2.1 Rising Government Healthcare Expenditure to Augment Growth
11.6.3 UAE
11.6.3.1 Increasing Emphasis on Healthy Lifestyles and Quality of Life to Encourage Growth
11.6.4 Rest of Middle East & Africa
12 Competitive Landscape
12.1 Introduction
12.2 Key Player Strategies/Right to Win
12.2.1 Overview of Major Strategies Adopted by Key Players in Hpv Testing and Pap Test Market
12.3 Revenue Analysis, 2022-2024
12.4 Market Share Analysis, 2024
12.5 Company Valuation and Financial Metrics
12.5.1 Company Valuation
12.5.2 Financial Metrics
12.6 Brand/Product Comparison
12.7 Company Evaluation Matrix: Key Players, 2024
12.7.1 Stars
12.7.2 Emerging Leaders
12.7.3 Pervasive Players
12.7.4 Participants
12.7.5 Company Footprint: Key Players, 2024
12.7.5.1 Company Footprint
12.7.5.2 Region Footprint
12.7.5.3 Product & Service Footprint
12.7.5.4 Test Type Footprint
12.7.5.5 Technology Footprint
12.8 Company Evaluation Matrix: Startups/SMEs, 2024
12.8.1 Progressive Companies
12.8.2 Responsive Companies
12.8.3 Dynamic Companies
12.8.4 Starting Blocks
12.8.5 Competitive Benchmarking: Startups/SMEs, 2024
12.8.5.1 Detailed List of Key Startups/SMEs
12.8.5.2 Competitive Benchmarking of Key Startups/SMEs
12.9 Competitive Scenario
12.9.1 Product Launches and Approvals
12.9.2 Deals
12.9.3 Expansions
13 Company Profiles
13.1 Key Players
13.1.1 Hologic, Inc.
13.1.1.1 Business Overview
13.1.1.2 Products Offered
13.1.1.3 Analyst's View
13.1.1.3.1 Right to Win
13.1.1.3.2 Strategic Choices
13.1.1.3.3 Weaknesses and Competitive Threats
13.1.2 Becton, Dickinson and Company (Bd)
13.1.2.1 Business Overview
13.1.2.2 Products Offered
13.1.2.3 Recent Developments
13.1.2.3.1 Product Launches and Approvals
13.1.2.3.2 Deals
13.1.2.3.3 Expansions
13.1.2.4 Analyst's View
13.1.2.4.1 Right to Win
13.1.2.4.2 Strategic Choices
13.1.2.4.3 Weaknesses and Competitive Threats
13.1.3 F. Hoffmann-La Roche Ltd.
13.1.3.1 Business Overview
13.1.3.2 Products Offered
13.1.3.3 Recent Developments
13.1.3.3.1 Product Launches and Approvals
13.1.3.4 Analyst's View
13.1.3.4.1 Right to Win
13.1.3.4.2 Strategic Choices
13.1.3.4.3 Weaknesses and Competitive Threats
13.1.4 Qiagen
13.1.4.1 Business Overview
13.1.4.2 Products Offered
13.1.4.3 Recent Developments
13.1.4.3.1 Expansions
13.1.4.4 Analyst's View
13.1.4.4.1 Right to Win
13.1.4.4.2 Strategic Choices
13.1.4.4.3 Weaknesses and Competitive Threats
13.1.5 Danaher Corporation
13.1.5.1 Business Overview
13.1.5.2 Products Offered
13.1.5.3 Analyst's View
13.1.5.3.1 Right to Win
13.1.5.3.2 Strategic Choices
13.1.5.3.3 Weaknesses and Competitive Threats
13.1.6 Abbott
13.1.6.1 Business Overview
13.1.6.2 Products Offered
13.1.6.3 Recent Developments
13.1.6.3.1 Product Launches and Approvals
13.1.6.3.2 Deals
13.1.7 Seegene Inc.
13.1.7.1 Business Overview
13.1.7.2 Products Offered
13.1.7.3 Recent Developments
13.1.7.3.1 Product Launches and Approvals
13.1.7.3.2 Deals
13.1.8 Sd Biosensor, Inc.
13.1.8.1 Business Overview
13.1.8.2 Products Offered
13.1.9 Sansure Biotech Inc.
13.1.9.1 Business Overview
13.1.9.2 Products Offered
13.1.9.3 Recent Developments
13.1.9.3.1 Product Launches and Approvals
13.1.9.3.2 Deals
13.1.10 Acon Laboratories, Inc.
13.1.10.1 Business Overview
13.1.10.2 Products Offered
13.2 Other Players
13.2.1 Molbio Diagnostics Limited
13.2.2 Ab Analitica S.R.L.
13.2.3 Certest Biotec
13.2.4 Atila Biosystems
13.2.5 Tellgen Corporation
13.2.6 Daan Gene Co. Ltd.
13.2.7 Jiangsu Bioperfectus Technologies Co. Ltd.
13.2.8 Anatolia Geneworks
13.2.9 Yaneng Bioscience (Shenzhen) Co. Ltd.
13.2.10 Xiamen Zeesan Biotech Co. Ltd.
13.2.11 Advanced Molecular Diagnostics (Amd)
13.2.12 Mylab Discovery Solutions Pvt. Ltd.
13.2.13 Sacace Biotechnologies Srl
13.2.14 Jiangsu Mole Bioscience Co. Ltd.
13.2.15 Hangzhou Alltest Biotech Co. Ltd.
13.2.16 Hangzhou Tongzhou Biotechnology Co. Ltd.
13.2.17 Nanjing Liming Biological Products Co. Ltd.
14 Appendix
14.1 Discussion Guide
14.2 Knowledgestore: The Subscription Portal
14.3 Customization Options
List of Tables
Table 1 Hpv Testing and Pap Test Market: Inclusions and Exclusions
Table 2 Hpv Testing and Pap Test Market: Key Data from Primary Sources
Table 3 Hpv Testing and Pap Test Market: Risk Assessment Analysis
Table 4 Estimated Number of New Cases of Cervical Cancer, by Region, 2022 vs. 2030
Table 5 Average Selling Pricing Trend of Hpv and Pap Tests, 2023-2025 (USD)
Table 6 Average Selling Pricing Trend of Hpv and Pap Tests, by Region (USD)
Table 7 Average Selling Price Trend of Hpv Tests, by Key Player, 2023-2025 (USD)
Table 8 Average Selling Price Trend of Hpv Tests, by Region, 2023-2025 (USD)
Table 9 Hpv Testing and Pap Test Market: Role of Companies in Ecosystem
Table 10 Hpv Testing and Pap Test Market: Key Conferences and Events, 2025-2026
Table 11 Hpv Testing and Pap Test Market: List of Major Patents, 2023-2025
Table 12 Import Data for HS Code 3822-Compliant Products, by Country, 2020-2024 (USD Million)
Table 13 Export Data for HS Code 3822-Compliant Products, by Country, 2020-2024 (USD Million)
Table 14 Classification of Ivd Devices in Europe
Table 15 Time, Cost, and Complexity of Registration Process in Japan
Table 16 North America: Regulatory Bodies, Government Agencies, and Other Organizations
Table 17 Europe: Regulatory Bodies, Government Agencies, and Other Organizations
Table 18 Asia-Pacific: Regulatory Bodies, Government Agencies, and Other Organizations
Table 19 Latin America: Regulatory Bodies, Government Agencies, and Other Organizations
Table 20 Rest of the World: Regulatory Bodies, Government Agencies, and Other Organizations
Table 21 Hpv Testing and Pap Test Market: Impact of Porter's Five Forces
Table 22 Influence of Stakeholders on Buying Process, by Product & Service (%)
Table 23 Key Buying Criteria, by Product & Service
Table 24 Reciprocal Tariff Rates Adjusted by US
Table 25 Hpv Testing and Pap Test Market, by Product & Service, 2023-2030 (USD Million)
Table 26 Key Consumables Available in Market
Table 27 Hpv Testing and Pap Test Consumables Market, by Region, 2023-2030 (USD Million)
Table 28 Key Instruments Available in Market
Table 29 Hpv Testing and Pap Test Instruments Market, by Region, 2023-2030 (USD Million)
Table 30 Hpv Testing and Pap Test Services Market, by Region, 2023-2030 (USD Million)
Table 31 Hpv Testing and Pap Test Market, by Test Type, 2023-2030 (USD Million)
Table 32 Key Hpv Testing Products Available in Market
Table 33 Hpv Testing Market, by Type, 2023-2030 (USD Million)
Table 34 Hpv Testing Market, by Region, 2023-2030 (USD Million)
Table 35 North America: Hpv Testing Market, by Country, 2023-2030 (USD Million)
Table 36 Europe: Hpv Testing Market, by Country, 2023-2030 (USD Million)
Table 37 Asia-Pacific: Hpv Testing Market, by Country, 2023-2030 (USD Million)
Table 38 Latin America: Hpv Testing Market, by Country, 2023-2030 (USD Million)
Table 39 Middle East & Africa: Hpv Testing Market, by Country, 2023-2030 (USD Million)
Table 40 Primary Hpv Testing Market, by Region, 2023-2030 (USD Million)
Table 41 North America: Primary Hpv Testing Market, by Country, 2023-2030 (USD Million)
Table 42 Europe: Primary Hpv Testing Market, by Country, 2023-2030 (USD Million)
Table 43 Asia-Pacific: Primary Hpv Testing Market, by Country, 2023-2030 (USD Million)
Table 44 Latin America: Primary Hpv Testing Market, by Country, 2023-2030 (USD Million)
Table 45 Middle East & Africa: Primary Hpv Testing Market, by Country, 2023-2030 (USD Million)
Table 46 Follow-Up Hpv Testing Market, by Region, 2023-2030 (USD Million)
Table 47 North America: Follow-Up Hpv Testing Market, by Country, 2023-2030 (USD Million)
Table 48 Europe: Follow-Up Hpv Testing Market, by Country, 2023-2030 (USD Million)
Table 49 Asia-Pacific: Follow-Up Hpv Testing Market, by Country, 2023-2030 (USD Million)
Table 50 Latin America: Follow-Up Hpv Testing Market, by Country, 2023-2030 (USD Million)
Table 51 Middle East & Africa: Follow-Up Hpv Testing Market, by Country, 2023-2030 (USD Million)
Table 52 Co-Testing Market, by Region, 2023-2030 (USD Million)
Table 53 North America: Co-Testing Market, by Country, 2023-2030 (USD Million)
Table 54 Europe: Co-Testing Market, by Country, 2023-2030 (USD Million)
Table 55 Asia-Pacific: Co-Testing Market, by Country, 2023-2030 (USD Million)
Table 56 Latin America: Co-Testing Market, by Country, 2023-2030 (USD Million)
Table 57 Middle East & Africa: Co-Testing Market, by Country, 2023-2030 (USD Million)
Table 58 Key Pap Tests Available in Market
Table 59 Pap Tests Market, by Region, 2023-2030 (USD Million)
Table 60 North America: Pap Tests Market, by Country, 2023-2030 (USD Million)
Table 61 Europe: Pap Tests Market, by Country, 2023-2030 (USD Million)
Table 62 Asia-Pacific: Pap Tests Market, by Country, 2023-2030 (USD Million)
Table 63 Latin America: Pap Tests Market, by Country, 2023-2030 (USD Million)
Table 64 Middle East & Africa: Pap Tests Market, by Country, 2023-2030 (USD Million)
Table 65 Hpv Testing and Pap Test Market, by Technology, 2023-2030 (USD Million)
Table 66 Key Molecular Diagnostic-based Products Available in Market
Table 67 Hpv Testing and Pap Test Market for Molecular Diagnostics, by Region, 2023-2030 (USD Million)
Table 68 North America: Hpv Testing and Pap Test Market for Molecular Diagnostics, by Country, 2023-2030 (USD Million)
Table 69 Europe: Hpv Testing and Pap Test Market for Molecular Diagnostics, by Country, 2023-2030 (USD Million)
Table 70 Asia-Pacific: Hpv Testing and Pap Test Market for Molecular Diagnostics, by Country, 2023-2030 (USD Million)
Table 71 Latin America: Hpv Testing and Pap Test Market for Molecular Diagnostics, by Country, 2023-2030 (USD Million)
Table 72 Middle East & Africa: Hpv Testing and Pap Test Market for Molecular Diagnostics, by Country, 2023-2030 (USD Million)
Table 73 Key Immunodiagnostic-based Products Available in Market
Table 74 Hpv Testing and Pap Test Market for Immunodiagnostics, by Region, 2023-2030 (USD Million)
Table 75 North America: Hpv Testing and Pap Test Market for Immunodiagnostics, by Country, 2023-2030 (USD Million)
Table 76 Europe: Hpv Testing and Pap Test Market for Immunodiagnostics, by Country, 2023-2030 (USD Million)
Table 77 Asia-Pacific: Hpv Testing and Pap Test Market for Immunodiagnostics, by Country, 2023-2030 (USD Million)
Table 78 Latin America: Hpv Testing and Pap Test Market for Immunodiagnostics, by Country, 2023-2030 (USD Million)
Table 79 Middle East & Africa: Hpv Testing and Pap Test Market for Immunodiagnostics, by Country, 2023-2030 (USD Million)
Table 80 Hpv Testing and Pap Test Market for Cytology, by Region, 2023-2030 (USD Million)
Table 81 North America: Hpv Testing and Pap Test Market for Cytology, by Country, 2023-2030 (USD Million)
Table 82 Europe: Hpv Testing and Pap Test Market for Cytology, by Country, 2023-2030 (USD Million)
Table 83 Asia-Pacific: Hpv Testing and Pap Test Market for Cytology, by Country, 2023-2030 (USD Million)
Table 84 Latin America: Hpv Testing and Pap Test Market for Cytology, by Country, 2023-2030 (USD Million)
Table 85 Middle East & Africa: Hpv Testing and Pap Test Market for Cytology, by Country, 2023-2030 (USD Million)
Table 86 Hpv Testing and Pap Test Market, by Application, 2023-2030 (USD Million)
Table 87 Key Hpv Testing and Pap Tests for Cervical Cancer Screening Available in Market
Table 88 Hpv Testing and Pap Test Market for Cervical Cancer Screening, by Region, 2023-2030 (USD Million)
Table 89 North America: Hpv Testing and Pap Test Market for Cervical Cancer Screening, by Country, 2023-2030 (USD Million)
Table 90 Europe: Hpv Testing and Pap Test Market for Cervical Cancer Screening, by Country, 2023-2030 (USD Million)
Table 91 Asia-Pacific: Hpv Testing and Pap Test Market for Cervical Cancer Screening, by Country, 2023-2030 (USD Million)
Table 92 Latin America: Hpv Testing and Pap Test Market for Cervical Cancer Screening, by Country, 2023-2030 (USD Million)
Table 93 Middle East & Africa: Hpv Testing and Pap Test Market for Cervical Cancer Screening, by Country, 2023-2030 (USD Million)
Table 94 Key Hpv Testing and Pap Tests for Vaginal Cancer Screening Available in Market
Table 95 Hpv Testing and Pap Test Market for Vaginal Cancer Screening, by Region, 2023-2030 (USD Million)
Table 96 North America: Hpv Testing and Pap Test Market for Vaginal Cancer Screening, by Country, 2023-2030 (USD Million)
Table 97 Europe: Hpv Testing and Pap Test Market for Vaginal Cancer Screening, by Country, 2023-2030 (USD Million)
Table 98 Asia-Pacific: Hpv Testing and Pap Test Market for Vaginal Cancer Screening, by Country, 2023-2030 (USD Million)
Table 99 Latin America: Hpv Testing and Pap Test Market for Vaginal Cancer Screening, by Country, 2023-2030 (USD Million)
Table 100 Middle East & Africa: Hpv Testing and Pap Test Market for Vaginal Cancer Screening, by Country, 2023-2030 (USD Million)
Table 101 Hpv Testing and Pap Test Market, by Care Setting, 2023-2030 (USD Million)
Table 102 Hpv Testing and Pap Test Market for Hospitals, by Region, 2023-2030 (USD Million)
Table 103 North America: Hpv Testing and Pap Test Market for Hospitals, by Country, 2023-2030 (USD Million)
Table 104 Europe: Hpv Testing and Pap Test Market for Hospitals, by Country, 2023-2030 (USD Million)
Table 105 Asia-Pacific: Hpv Testing and Pap Test Market for Hospitals, by Country, 2023-2030 (USD Million)
Table 106 Latin America: Hpv Testing and Pap Test Market for Hospitals, by Country, 2023-2030 (USD Million)
Table 107 Middle East & Africa: Hpv Testing and Pap Test Market for Hospitals, by Country, 2023-2030 (USD Million)
Table 108 Hpv Testing and Pap Test Market for Diagnostic Laboratories, by Region, 2023-2030 (USD Million)
Table 109 North America: Hpv Testing and Pap Test Market for Diagnostic Laboratories, by Country, 2023-2030 (USD Million)
Table 110 Europe: Hpv Testing and Pap Test Market for Diagnostic Laboratories, by Country, 2023-2030 (USD Million)
Table 111 Asia-Pacific: Hpv Testing and Pap Test Market for Diagnostic Laboratories, by Country, 2023-2030 (USD Million)
Table 112 Latin America: Hpv Testing and Pap Test Market for Diagnostic Laboratories, by Country, 2023-2030 (USD Million)
Table 113 Middle East & Africa: Hpv Testing and Pap Test Market for Diagnostic Laboratories, by Country, 2023-2030 (USD Million)
Table 114 Hpv Testing and Pap Test Market for Physicians’ Offices & Clinics, by Region, 2023-2030 (USD Million)
Table 115 North America: Hpv Testing and Pap Test Market for Physicians’ Offices & Clinics, by Country, 2023-2030 (USD Million)
Table 116 Europe: Hpv Testing and Pap Test Market for Physicians’ Offices & Clinics, by Country, 2023-2030 (USD Million)
Table 117 Asia-Pacific: Hpv Testing and Pap Test Market for Physicians’ Offices & Clinics, by Country, 2023-2030 (USD Million)
Table 118 Latin America: Hpv Testing and Pap Test Market for Physicians’ Offices & Clinics, by Country, 2023-2030 (USD Million)
Table 119 Middle East & Africa: Hpv Testing and Pap Test Market for Physicians’ Offices & Clinics, by Country, 2023-2030 (USD Million)
Table 120 Projected Cervical Cancer Cases, by Country, 2022 vs. 2030
Table 121 Hpv Testing and Pap Test Market, by Region, 2023-2030 (USD Million)
Table 122 Total Number of Hpv Tests Conducted, by Region, 2023-2030 (Million Unit)
Table 123 Total Number of Pap Tests Conducted, by Region, 2023-2030 (Million Unit)
Table 124 North America: Key Macroeconomic Indicators
Table 125 North America: Hpv Testing and Pap Test Market, by Country, 2023-2030 (USD Million)
Table 126 North America: Hpv Testing and Pap Test Market, by Product & Service, 2023-2030 (USD Million)
Table 127 North America: Hpv Testing and Pap Test Market, by Test Type, 2023-2030 (USD Million)
Table 128 North America: Hpv Testing Market, by Type, 2023-2030 (USD Million)
Table 129 North America: Hpv Testing and Pap Test Market, by Technology, 2023-2030 (USD Million)
Table 130 North America: Hpv Testing and Pap Test Market, by Application, 2023-2030 (USD Million)
Table 131 North America: Hpv Testing and Pap Test Market, by Care Setting, 2023-2030 (USD Million)
Table 132 US: Hpv Testing and Pap Test Market, by Test Type, 2023-2030 (USD Million)
Table 133 US: Hpv Testing Market, by Type, 2023-2030 (USD Million)
Table 134 US: Hpv Testing and Pap Test Market, by Technology, 2023-2030 (USD Million)
Table 135 US: Hpv Testing and Pap Test Market, by Application, 2023-2030 (USD Million)
Table 136 US: Hpv Testing and Pap Test Market, by Care Setting, 2023-2030 (USD Million)
Table 137 Canada: Hpv Testing and Pap Test Market, by Test Type, 2023-2030 (USD Million)
Table 138 Canada: Hpv Testing Market, by Type, 2023-2030 (USD Million)
Table 139 Canada: Hpv Testing and Pap Test Market, by Technology, 2023-2030 (USD Million)
Table 140 Canada: Hpv Testing and Pap Test Market, by Application, 2023-2030 (USD Million)
Table 141 Canada: Hpv Testing and Pap Test Market, by Care Setting, 2023-2030 (USD Million)
Table 142 Europe: Hpv Testing and Pap Test Market, by Country, 2023-2030 (USD Million)
Table 143 Europe: Hpv Testing and Pap Test Market, by Product & Service, 2023-2030 (USD Million)
Table 144 Europe: Hpv Testing and Pap Test Market, by Test Type, 2023-2030 (USD Million)
Table 145 Europe: Hpv Testing Market, by Type, 2023-2030 (USD Million)
Table 146 Europe: Hpv Testing and Pap Test Market, by Technology, 2023-2030 (USD Million)
Table 147 Europe: Hpv Testing and Pap Test Market, by Application, 2023-2030 (USD Million)
Table 148 Europe: Hpv Testing and Pap Test Market, by Care Setting, 2023-2030 (USD Million)
Table 149 Germany: Hpv Testing and Pap Test Market, by Test Type, 2023-2030 (USD Million)
Table 150 Germany: Hpv Testing Market, by Type, 2023-2030 (USD Million)
Table 151 Germany: Hpv Testing and Pap Test Market, by Technology, 2023-2030 (USD Million)
Table 152 Germany: Hpv Testing and Pap Test Market, by Application, 2023-2030 (USD Million)
Table 153 Germany: Hpv Testing and Pap Test Market, by Care Setting, 2023-2030 (USD Million)
Table 154 UK: Hpv Testing and Pap Test Market, by Test Type, 2023-2030 (USD Million)
Table 155 UK: Hpv Testing Market, by Type, 2023-2030 (USD Million)
Table 156 UK: Hpv Testing and Pap Test Market, by Technology, 2023-2030 (USD Million)
Table 157 UK: Hpv Testing and Pap Test Market, by Application, 2023-2030 (USD Million)
Table 158 UK: Hpv Testing and Pap Test Market, by Care Setting, 2023-2030 (USD Million)
Table 159 France: Hpv Testing and Pap Test Market, by Test Type, 2023-2030 (USD Million)
Table 160 France: Hpv Testing Market, by Type, 2023-2030 (USD Million)
Table 161 France: Hpv Testing and Pap Test Market, by Technology, 2023-2030 (USD Million)
Table 162 France: Hpv Testing and Pap Test Market, by Application, 2023-2030 (USD Million)
Table 163 France: Hpv Testing and Pap Test Market, by Care Setting, 2023-2030 (USD Million)
Table 164 Italy: Hpv Testing and Pap Test Market, by Test Type, 2023-2030 (USD Million)
Table 165 Italy: Hpv Testing Market, by Type, 2023-2030 (USD Million)
Table 166 Italy: Hpv Testing and Pap Test Market, by Technology, 2023-2030 (USD Million)
Table 167 Italy: Hpv Testing and Pap Test Market, by Application, 2023-2030 (USD Million)
Table 168 Italy: Hpv Testing and Pap Test Market, by Care Setting, 2023-2030 (USD Million)
Table 169 Spain: Hpv Testing and Pap Test Market, by Test Type, 2023-2030 (USD Million)
Table 170 Spain: Hpv Testing Market, by Type, 2023-2030 (USD Million)
Table 171 Spain: Hpv Testing and Pap Test Market, by Technology, 2023-2030 (USD Million)
Table 172 Spain: Hpv Testing and Pap Test Market, by Application, 2023-2030 (USD Million)
Table 173 Spain: Hpv Testing and Pap Test Market, by Care Setting, 2023-2030 (USD Million)
Table 174 Rest of Europe: Hpv Testing and Pap Test Market, by Test Type, 2023-2030 (USD Million)
Table 175 Rest of Europe: Hpv Testing Market, by Type, 2023-2030 (USD Million)
Table 176 Rest of Europe: Hpv Testing and Pap Test Market, by Technology, 2023-2030 (USD Million)
Table 177 Rest of Europe: Hpv Testing and Pap Test Market, by Application, 2023-2030 (USD Million)
Table 178 Rest of Europe: Hpv Testing and Pap Test Market, by Care Setting, 2023-2030 (USD Million)
Table 179 Asia-Pacific: Key Macroeconomic Indicators
Table 180 Asia-Pacific: Hpv Testing and Pap Test Market, by Country, 2023-2030 (USD Million)
Table 181 Asia-Pacific: Hpv Testing and Pap Test Market, by Product & Service, 2023-2030 (USD Million)
Table 182 Asia-Pacific: Hpv Testing and Pap Test Market, by Test Type, 2023-2030 (USD Million)
Table 183 Asia-Pacific: Hpv Testing Market, by Type, 2023-2030 (USD Million)
Table 184 Asia-Pacific: Hpv Testing and Pap Test Market, by Technology, 2023-2030 (USD Million)
Table 185 Asia-Pacific: Hpv Testing and Pap Test Market, by Application, 2023-2030 (USD Million)
Table 186 Asia-Pacific: Hpv Testing and Pap Test Market, by Care Setting, 2023-2030 (USD Million)
Table 187 China: Hpv Testing and Pap Test Market, by Test Type, 2023-2030 (USD Million)
Table 188 China: Hpv Testing Market, by Type, 2023-2030 (USD Million)
Table 189 China: Hpv Testing and Pap Test Market, by Technology, 2023-2030 (USD Million)
Table 190 China: Hpv Testing and Pap Test Market, by Application, 2023-2030 (USD Million)
Table 191 China: Hpv Testing and Pap Test Market, by Care Setting, 2023-2030 (USD Million)
Table 192 Japan: Hpv Testing and Pap Test Market, by Test Type, 2023-2030 (USD Million)
Table 193 Japan: Hpv Testing Market, by Type, 2023-2030 (USD Million)
Table 194 Japan: Hpv Testing and Pap Test Market, by Technology, 2023-2030 (USD Million)
Table 195 Japan: Hpv Testing and Pap Test Market, by Application, 2023-2030 (USD Million)
Table 196 Japan: Hpv Testing and Pap Test Market, by Care Setting, 2023-2030 (USD Million)
Table 197 India: Hpv Testing and Pap Test Market, by Test Type, 2023-2030 (USD Million)
Table 198 India: Hpv Testing Market, by Type, 2023-2030 (USD Million)
Table 199 India: Hpv Testing and Pap Test Market, by Technology, 2023-2030 (USD Million)
Table 200 India: Hpv Testing and Pap Test Market, by Application, 2023-2030 (USD Million)
Table 201 India: Hpv Testing and Pap Test Market, by Care Setting, 2023-2030 (USD Million)
Table 202 Rest of Asia-Pacific: Hpv Testing and Pap Test Market, by Test Type, 2023-2030 (USD Million)
Table 203 Rest of Asia-Pacific: Hpv Testing Market, by Type, 2023-2030 (USD Million)
Table 204 Rest of Asia-Pacific: Hpv Testing and Pap Test Market, by Technology, 2023-2030 (USD Million)
Table 205 Rest of Asia-Pacific: Hpv Testing and Pap Test Market, by Application, 2023-2030 (USD Million)
Table 206 Rest of Asia-Pacific: Hpv Testing and Pap Test Market, by Care Setting, 2023-2030 (USD Million)
Table 207 Latin America: Key Macroeconomic Indicators
Table 208 Latin America: Hpv Testing and Pap Test Market, by Country, 2023-2030 (USD Million)
Table 209 Latin America: Hpv Testing and Pap Test Market, by Product & Service, 2023-2030 (USD Million)
Table 210 Latin America: Hpv Testing and Pap Test Market, by Test Type, 2023-2030 (USD Million)
Table 211 Latin America: Hpv Testing Market, by Type, 2023-2030 (USD Million)
Table 212 Latin America: Hpv Testing and Pap Test Market, by Technology, 2023-2030 (USD Million)
Table 213 Latin America: Hpv Testing and Pap Test Market, by Application, 2023-2030 (USD Million)
Table 214 Latin America: Hpv Testing and Pap Test Market, by Care Setting, 2023-2030 (USD Million)
Table 215 Brazil: Hpv Testing and Pap Test Market, by Test Type, 2023-2030 (USD Million)
Table 216 Brazil: Hpv Testing Market, by Type, 2023-2030 (USD Million)
Table 217 Brazil: Hpv Testing and Pap Test Market, by Technology, 2023-2030 (USD Million)
Table 218 Brazil: Hpv Testing and Pap Test Market, by Application, 2023-2030 (USD Million)
Table 219 Brazil: Hpv Testing and Pap Test Market, by Care Setting, 2023-2030 (USD Million)
Table 220 Mexico: Hpv Testing and Pap Test Market, by Test Type, 2023-2030 (USD Million)
Table 221 Mexico: Hpv Testing Market, by Type, 2023-2030 (USD Million)
Table 222 Mexico: Hpv Testing and Pap Test Market, by Technology, 2023-2030 (USD Million)
Table 223 Mexico: Hpv Testing and Pap Test Market, by Application, 2023-2030 (USD Million)
Table 224 Mexico: Hpv Testing and Pap Test Market, by Care Setting, 2023-2030 (USD Million)
Table 225 Rest of Latin America: Hpv Testing and Pap Test Market, by Test Type, 2023-2030 (USD Million)
Table 226 Rest of Latin America: Hpv Testing Market, by Type, 2023-2030 (USD Million)
Table 227 Rest of Latin America: Hpv Testing and Pap Test Market, by Technology, 2023-2030 (USD Million)
Table 228 Rest of Latin America: Hpv Testing and Pap Test Market, by Application, 2023-2030 (USD Million)
Table 229 Rest of Latin America: Hpv Testing and Pap Test Market, by Care Setting, 2023-2030 (USD Million)
Table 230 Middle East & Africa: Key Macroeconomic Indicators
Table 231 Middle East & Africa: Hpv Testing and Pap Test Market, by Country, 2023-2030 (USD Million)
Table 232 Middle East & Africa: Hpv Testing and Pap Test Market, by Product & Service, 2023-2030 (USD Million)
Table 233 Middle East & Africa: Hpv Testing and Pap Test Market, by Test Type, 2023-2030 (USD Million)
Table 234 Middle East & Africa: Hpv Testing Market, by Type, 2023-2030 (USD Million)
Table 235 Middle East & Africa: Hpv Testing and Pap Test Market, by Technology, 2023-2030 (USD Million)
Table 236 Middle East & Africa: Hpv Testing and Pap Test Market, by Application, 2023-2030 (USD Million)
Table 237 Middle East & Africa: Hpv Testing and Pap Test Market, by Care Setting, 2023-2030 (USD Million)
Table 238 Saudi Arabia: Hpv Testing and Pap Test Market, by Test Type, 2023-2030 (USD Million)
Table 239 Saudi Arabia: Hpv Testing Market, by Type, 2023-2030 (USD Million)
Table 240 Saudi Arabia: Hpv Testing and Pap Test Market, by Technology, 2023-2030 (USD Million)
Table 241 Saudi Arabia: Hpv Testing and Pap Test Market, by Application, 2023-2030 (USD Million)
Table 242 Saudi Arabia: Hpv Testing and Pap Test Market, by Care Setting, 2023-2030 (USD Million)
Table 243 UAE: Hpv Testing and Pap Test Market, by Test Type, 2023-2030 (USD Million)
Table 244 UAE: Hpv Testing Market, by Type, 2023-2030 (USD Million)
Table 245 UAE: Hpv Testing and Pap Test Market, by Technology, 2023-2030 (USD Million)
Table 246 UAE: Hpv Testing and Pap Test Market, by Application, 2023-2030 (USD Million)
Table 247 UAE: Hpv Testing and Pap Test Market, by Care Setting, 2023-2030 (USD Million)
Table 248 Rest of Middle East & Africa: Hpv Testing and Pap Test Market, by Test Type, 2023-2030 (USD Million)
Table 249 Rest of Middle East & Africa: Hpv Testing Market, by Type, 2023-2030 (USD Million)
Table 250 Rest of Middle East & Africa: Hpv Testing and Pap Test Market, by Technology, 2023-2030 (USD Million)
Table 251 Rest of Middle East & Africa: Hpv Testing and Pap Test Market, by Application, 2023-2030 (USD Million)
Table 252 Rest of Middle East & Africa: Hpv Testing and Pap Test Market, by Care Setting, 2023-2030 (USD Million)
Table 253 Overview of Major Strategies Deployed by Key Players in Hpv Testing and Pap Test Market, January 2022-September 2025
Table 254 Hpv Testing and Pap Test Market: Degree of Competition
Table 255 Hpv Testing and Pap Test Market: Region Footprint
Table 256 Hpv Testing and Pap Test Market: Product & Service Footprint
Table 257 Hpv Testing and Pap Test Market: Test Type Footprint
Table 258 Hpv Testing and Pap Test Market: Technology Footprint
Table 259 Hpv Testing and Pap Test Market: Detailed List of Key Startups/SMEs
Table 260 Hpv Testing and Pap Test Market: Competitive Benchmarking of Key Startups/SMEs, by Product & Service and Test Type
Table 261 Hpv Testing and Pap Test Market: Competitive Benchmarking of Key Startups/SMEs, by Region
Table 262 Hpv Testing and Pap Test Market: Product Launches and Approvals, January 2022-September 2025
Table 263 Hpv Testing and Pap Test Market: Deals, January 2022-September 2025
Table 264 Hpv Testing and Pap Test Market: Expansions, January 2022-September 2025
Table 265 Hologic, Inc.: Company Overview
Table 266 Hologic, Inc.: Products Offered
Table 267 Becton, Dickinson and Company (Bd): Company Overview
Table 268 Becton, Dickinson and Company (Bd): Products Offered
Table 269 Becton, Dickinson and Company (Bd): Product Launches and Approvals, January 2022-September 2025
Table 270 Becton, Dickinson and Company (Bd): Deals, January 2022-September 2025
Table 271 Becton, Dickinson and Company (Bd): Expansions, January 2022-September 2025
Table 272 F. Hoffmann-La Roche Ltd.: Company Overview
Table 273 F. Hoffmann-La Roche Ltd.: Products Offered
Table 274 F. Hoffman-La Roche Ltd.: Product Launches and Approvals, January 2022-September 2025
Table 275 Qiagen: Company Overview
Table 276 Qiagen: Products Offered
Table 277 Qiagen: Expansions, January 2022-September 2025
Table 278 Danaher Corporation: Company Overview
Table 279 Danaher Corporation: Products Offered
Table 280 Abbott: Company Overview
Table 281 Abbott: Products Offered
Table 282 Abbott: Product Launches and Approvals, January 2022-September 2025
Table 283 Abbott: Deals, January 2022-September 2025
Table 284 Seegene Inc.: Company Overview
Table 285 Seegene Inc.: Products Offered
Table 286 Seegene Inc.: Product Launches and Approvals, January 2022-September 2025
Table 287 Seegene Inc.: Deals, January 2022-September 2025
Table 288 Sd Biosensor, Inc.: Company Overview
Table 289 Sd Biosensor, Inc.: Products Offered
Table 290 Sansure Biotech Inc.: Company Overview
Table 291 Sansure Biotech Inc.: Products Offered
Table 292 Sansure Biotech Inc.: Product Launches and Approvals, January 2022-September 2025
Table 293 Sansure Biotech Inc.: Deals, January 2022-September 2025
Table 294 Acon Laboratories, Inc.: Company Overview
Table 295 Acon Laboratories, Inc.: Products Offered
Table 296 Molbio Diagnostics Limited: Company Overview
Table 297 Ab Analitica S.R.L.: Company Overview
Table 298 Certest Biotec: Company Overview
Table 299 Atila Biosystems: Company Overview
Table 300 Tellgen Corporation: Company Overview
Table 301 Daan Gene Co. Ltd.: Company Overview
Table 302 Jiangsu Bioperfectus Technologies Co. Ltd.: Company Overview
Table 303 Anatolia Geneworks: Company Overview
Table 304 Yaneng Bioscience (Shenzhen) Co. Ltd.: Company Overview
Table 305 Xiamen Zeesan Biotech Co. Ltd.: Company Overview
Table 306 Advanced Molecular Diagnostics (Amd): Company Overview
Table 307 Mylab Discovery Solutions Pvt. Ltd.: Company Overview
Table 308 Sacace Biotechnologies Srl: Company Overview
Table 309 Jiangsu Mole Bioscience Co. Ltd.: Company Overview
Table 310 Hangzhou Alltest Biotech Co. Ltd.: Company Overview
Table 311 Hangzhou Tongzhou Biotechnology Co. Ltd.: Company Overview
Table 312 Nanjing Liming Biological Products Co. Ltd.: Company Overview
List of Figures
Figure 1 Hpv Testing and Pap Test Market Segmentation and Regional Scope
Figure 2 Hpv Testing and Pap Test Market: Research Design Methodology
Figure 3 Primary Sources
Figure 4 Key Industry Insights
Figure 5 Breakdown of Primary Interviews: Supply-Side and Demand-Side Participants
Figure 6 Breakdown of Primary Interviews: by Company Type, Designation, and Region
Figure 7 Bottom-Up Approach: Company Revenue Estimation Approach
Figure 8 CAGR Projections: Supply-Side Analysis
Figure 9 Epidemiology-based Test Volume Estimation Approach
Figure 10 Hpv Testing and Pap Test Market: Top-Down Approach
Figure 11 Data Triangulation Methodology
Figure 12 Hpv Testing and Pap Test Market: Research Assumptions
Figure 13 Hpv Testing and Pap Test Market, by Product & Service, 2025 vs. 2030 (USD Million)
Figure 14 Hpv Testing and Pap Test Market, by Test Type, 2025 vs. 2030 (USD Million)
Figure 15 Hpv Testing and Pap Test Market, by Technology, 2025 vs. 2030(USD Million)
Figure 16 Hpv Testing and Pap Test Market, by Application, 2025 vs. 2030 (USD Million)
Figure 17 Hpv Testing and Pap Test Market, by Care Setting, 2025 vs. 2030 (USD Million)
Figure 18 Hpv Testing and Pap Test Market, by Region, 2025 vs. 2030 (USD Million)
Figure 19 Rising Cases of Hpv and Increasing R&D Initiatives on Cervical Cancer Screening to Drive Market
Figure 20 Consumables Segment to Dominate Market During Forecast Period
Figure 21 Hpv Testing Segment to Dominate Market During Forecast Period
Figure 22 Molecular Diagnostics Segment to Showcase Largest Market Share During Forecast Period
Figure 23 Cervical Cancer Screening Segment to Account for Largest Market Share During Forecast Period
Figure 24 Hospitals Segment to Continue to Dominate Market in 2030
Figure 25 North American Market to Account for Largest Share During Forecast Period
Figure 26 Hpv Testing and Pap Test Market: Drivers, Restraints, Opportunities, and Challenges
Figure 27 New Revenue Pockets for Players in Hpv Testing and Pap Test Market
Figure 28 Hpv Testing and Pap Test Market: Value Chain Analysis
Figure 29 Hpv Testing and Pap Test Market: Supply Chain Analysis
Figure 30 Hpv Testing and Pap Test Market: Ecosystem Analysis
Figure 31 Hpv Testing and Pap Test Market: Investment and Funding Scenario, 2022-2025
Figure 32 Hpv Testing and Pap Test Market: Patent Analysis, January 2015-December 2024
Figure 33 Hpv Testing and Pap Test Market: Porter's Five Forces Analysis
Figure 34 Influence of Stakeholders on Buying Process, by Product & Service
Figure 35 Key Buying Criteria, by Product & Service
Figure 36 Market Potential of AI in Hpv Testing and Pap Test Market
Figure 37 North America: Hpv Testing and Pap Test Market Snapshot
Figure 38 Asia-Pacific: Hpv Testing and Pap Test Market Snapshot
Figure 39 Revenue Analysis of Key Players in Hpv Testing and Pap Test Market, 2022-2024
Figure 40 Market Share Analysis of Key Players in Hpv Testing and Pap Test Market, 2024
Figure 41 Year-To-Date (YTD) Price, Total Return, and 5-Year Stock Beta of Key Vendors
Figure 42 EV/EBITDA of Key Vendors
Figure 43 Hpv Testing and Pap Test Market: Brand/Product Comparative Analysis
Figure 44 Hpv Testing and Pap Test Market: Company Evaluation Matrix (Key Players), 2024
Figure 45 Hpv Testing and Pap Test Market: Company Footprint
Figure 46 Hpv Testing and Pap Test Market: Company Evaluation Matrix (Startups/SMEs), 2024
Figure 47 Hologic, Inc.: Company Snapshot
Figure 48 Becton, Dickinson and Company (Bd): Company Snapshot
Figure 49 F. Hoffmann-La Roche Ltd.: Company Snapshot
Figure 50 Qiagen: Company Snapshot
Figure 51 Danaher Corporation: Company Snapshot
Figure 52 Abbott: Company Snapshot
Figure 53 Seegene Inc.: Company Snapshot
Figure 54 Sd Biosensor, Inc.: Company Snapshot

Companies Mentioned

The key companies profiled in this Human Papilloma Virus/HPV Test and Pap Smear/Test market report include:
  • Hologic, Inc.
  • Becton, Dickinson and Company (Bd)
  • F. Hoffmann-La Roche Ltd.
  • Qiagen
  • Danaher Corporation
  • Abbott
  • Seegene Inc.
  • Sd Biosensor, Inc.
  • Sansure Biotech Inc.
  • Acon Laboratories, Inc.
  • Molbio Diagnostics Limited
  • Ab Analitica S.R.L.
  • Certest Biotec
  • Atila Biosystems
  • Tellgen Corporation
  • Daan Gene Co. Ltd.
  • Jiangsu Bioperfectus Technologies Co. Ltd.
  • Anatolia Geneworks
  • Yaneng Bioscience (Shenzhen) Co. Ltd.
  • Xiamen Zeesan Biotech Co. Ltd.
  • Advanced Molecular Diagnostics (Amd)
  • Mylab Discovery Solutions Pvt. Ltd.
  • Sacace Biotechnologies Srl
  • Jiangsu Mole Bioscience Co. Ltd.
  • Hangzhou Alltest Biotech Co. Ltd.
  • Hangzhou Tongzhou Biotechnology Co. Ltd.
  • Nanjing Liming Biological Products Co. Ltd.

Table Information